Equibles does not estimate personal net worth.
Get an email with a short summary when Ani Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get ANIP alertsMary Powell has spoken on 1 earnings call across 1 company, most recently for Ani Pharmaceuticals Inc on November 5, 2026. Ani Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Ani Pharmaceuticals Inc includes Nikhil Lalwani (CEO and Board Member), Patrick D. Walsh (CEO and Board Member), Thomas J. Haughey (Chairman) and 7 others.
“Thank you, Nikhil, and good morning, everyone, and I'm very pleased to be joining today's call to introduce you all to MCT8 deficiency and also to MCT8. MCT-8 deficiency is a rare endocrinologic disease, and it's characterized by two somewhat conflicting or contrasting conditions.”
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
